UnitedHealth (UNH) issued a statement saying: “The Wall Street Journal continues to report misinformation on the Medicare Advantage program. The government regularly reviews all MA plans to ensure compliance and we consistently perform at the industry’s highest levels on those reviews. We are not aware of the “launch” of any “new” activity as reported by the Journal. We are aware, however, that the Journal has engaged in a year-long campaign to defend a legacy system that rewards volume over keeping patients healthy and addressing their underlying conditions. Any suggestion that our practices are fraudulent is outrageous and false.”
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth tells Bloomberg that WSJ report ‘misinformation’
- Morning Movers: Bluebird Bio shares tumble following take-private deal
- Reaction to WSJ report on UnitedHealth ‘overdone,’ says RBC Capital
- UNH Stock Plummets on DOJ Probe Report
- DOJ investigating UnitedHealth Medicare billing practices, WSJ reports